DNDebadatta Nayak

Debadatta Nayak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Debadatta Nayak has a total of 250 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Nutritional determinants of non-alcoholic fatty liver disease: a machine learning approach with nutritional scoring

    by Joyeta Ghosh, Partha Pratim Pal, Poulami Dasgupta, Debprasad Chattopadhyay, Debdutta Nayak

    Background and aims: Non-alcoholic fatty liver disease (NAFLD) affects roughly a quarter of adults worldwide, and diet is considered a modifiable determinant. Models that include the variables defining NAFLD may overstate the contribution of diet, an effect that has not been quantified. We examined associations of diet, fast-food and soda consumption, and physical inactivity with NAFLD in Korean adults, compared machine learning classifiers under leakage-controlled conditions, and evaluated a Nutritional Liver Risk Score (NLRS). Methods: We analysed pooled 2008–2011 data from the Korea National Health and Nutrition Examination Survey (KNHANES). After removing 12,604 duplicated records and applying exclusions, 18,506 adults remained. NAFLD was defined as a hepatic steatosis index (HSI) above 36; alanine aminotransferase (ALT) served as a second, BMI-independent outcome. Diet was assessed by one 24-h recall. Analyses comprised non-parametric tests, correlations, survey-weighted regression, effect modification, E-values, measurement-error scenarios, and eight tuned classifiers evaluated by nested 10-fold cross-validation grouped by primary sampling unit across feature sets progressively excluding the HSI components. The NLRS was validated temporally. Results: NAFLD prevalence was 20.9%. Models including the HSI components reached an area under the receiver operating characteristic curve (AUROC) of 0.998, reflecting circularity; excluding them gave 0.897, and 0.747 without waist circumference and glucose. Diet with age and lifestyle gave an AUROC of 0.595 versus 0.597 for age and lifestyle alone. Fibre, sodium and potassium showed small positive associations (adjusted odds ratio [aOR] 1.03–1.06); fat and carbohydrate showed none. Soda consumption was consistently associated with NAFLD (aOR 1.11 per SD) and physical inactivity with elevated ALT (aOR 1.20, E-value 1.4), confined to men; fast food showed a weak association. Continuous ALT differed by 3% or less. The NLRS did not discriminate NAFLD in temporal validation (AUROC 0.512). Conclusion: Diet showed small associations with HSI-defined NAFLD and added little to prediction beyond age and lifestyle; near-perfect accuracy of models containing the HSI components is circular. Soda consumption and physical inactivity were the most consistent associations, but the cross-sectional design cannot establish causation. The feature-set framework and open code offer a template for leakage-controlled evaluation.

  • Molecular insights and therapeutic innovations in low-risk human papillomavirus-associated cutaneous wart

    by Avipsha Sarkar, Sayaree Pan, Tanusree Ghorai, Debadatta Nayak, Satadal Das

  • Open Access

    Healthcare Utilization Patterns for Acute Undifferentiated Febrile Illness in an Urban Slum of Delhi: A Prospective Cohort Study

    by Debadatta Nayak, Roja Varanasi, Rajiv Janardhanan, Simran Tandon, Sanghamitra Pati

    Objective: Acute undifferentiated febrile illness (AUFI) imposes a significant burden on individuals and the healthcare system, particularly in densely populated urban slums. In the context of rising antibiotic resistance driven by widespread self-medication and over-the-counter drug use, understanding care-seeking behavior in resource-constrained settings is essential for effective resource management and equitable public health interventions. This study examined healthcare utilization patterns among residents of an urban slum in Delhi experiencing AUFI. Methods: This prospective longitudinal cohort study assessed healthcare utilization patterns for AUFI using a structured interviewer-administered questionnaire over 18 months. The outcome measures were the type of healthcare facility accessed and the medical discipline consulted by individuals with AUFI episodes. Results: A total of 1,497 individuals were included, with 1,278 AUFI episodes recorded. Government hospitals were the most utilized (64.8%), followed by self-medication (18.9%), while private facilities had minimal use. Allopathy was the predominant medical discipline (84.7%), followed by homeopathy (6.9%), Unani (2.7%), Ayurveda (2.2%), and other unclassified practices (3.5%). Age and sex did not significantly influence healthcare choices, whereas socioeconomic status significantly affected the choice of medical discipline. The socioeconomic status was the key determinant of care-seeking behavior; while age, sex, and duration of symptoms had no significant influence. Conclusion: Government hospitals and allopathic treatment were the primary choices, followed by self-medication. Socioeconomic status emerged as a key determinant of care-seeking behavior.

  • Open Access

    Symphytum officinale enhances fracture healing in Wistar albino rats by promoting osteogenesis in fracture callus

    by S. Tyagi, P.K. Pagaku, V. Shrivastava, D. Dey, A. Aryal, A. Bhattacharya, S. Rani, B. Garg, P. Khanna, A. Goyal, et al.

  • Eupatorium perfoliatum Counteracts TNF-α Mediated Pathogenesis in Chikungunya Virus Infection

    by Avipsha Sarkar, Anirban Roy, Tanusree Ghorai, Bijita Bhowmick, Madhulina Maity, Pritam Chandra, Debadatta Nayak, Subhash Kaushik, Satadal Das

    Chikungunya virus (CHIKV) infection, a neglected tropical disease causes severe morbid symptoms that can be persistent and debilitating. CHIKV mediated pathogenesis is a complex combination of host and viral factors that results in immune responses causing incapacitating symptoms. A significant player of disease development is tumor necrosis factor-α (TNF-α), the villain responsible for unremitting inflammation and disease pathogenesis. This study explored the potential of TNF-α dysregulation that can enhance CHIKV mediated disease development along with the prospective of ultradiluted hydroethanolic preparation of Eupatorium perfoliatum to limit the symptoms. In silico molecular docking studies revealed that Eupatorium perfoliatum has strong molecular interactions with TNF-α. To substantiate the results, in vivo transcriptional and translational quantification of TNF-α by qRT-PCR and immunohistochemistry before and after treatment with candidate medicine was performed which produced similar outcome. Macroscopic and histology results also revealed neuropathogenesis and muscle waste caused by CHIKV infection and a systemic lowering of the same after treatment. Hub genes of TNF-α were analyzed to identify the other probable players that can augment CHIKV mediated pathogenesis. qRT-PCR results showed that the candidate medicine could lower the transcriptional overexpression of the hub genes thereby lowering disease pathogenesis. In vitro cytopathic effects upon infection were also lowered by the candidate medicine. Therefore, this study helps not only to recognize the possible villainous role of TNF-α but to also identify novel therapeutic markers of CHIKV mediated disease development by hub gene analysis and the potential of the alternative medicine, ultradiluted Eupatorium perfoliatum in lowering the same. Graphical Abstract

  • Retraction
    Open Access

    Retraction Note: Homoeopathy vs. conventional primary care in children during the first 24 months of life—a pragmatic randomised controlled trial

    by Menachem Oberbaum, Anupriya Chaudhary, Hima Bindu Ponnam, Reetha Krishnan, Dinesh V. Kumar, Mohammed Irfan, Debadatta Nayak, Swati Pandey, Akula Archana, Sai Bhargavi, et al.

  • Adherence to Prophylactic Use of Homeopathic Arsenicum album during COVID-19 in India: A Cross-Sectional Study in 23 Cities

    by Debadatta Nayak, Karanpreet Nahar, Lovepreet Kaur, Smita Singh, Hima Bindu Ponnam, Birendra Singh Rawat, Akhyaya Kumar Prusty, Umakanta Prusty, Liyi Karso, Lipipushpa Debata, et al.

    The Indian government, in response to the coronavirus disease 2019 (COVID-19) pandemic, initiated campaigns to use complementary therapies for its prevention and control, such as large-scale distribution of the homeopathic medicine, Arsenicum album 30C, as potential prophylactic for COVID-19. This study estimates the individual adherence to using this homeopathic prophylactic within the Indian urban population.A multi-center, cross-sectional, study was conducted across 23 cities in 19 Indian states and union territories from September to November 2022. Participants aged 18 years and above, who had received Arsenicum album 30C within the past month, were included. Adherence was assessed through self-reports. Data were collected in a structured data collection form. Factors influencing adherence were analysed using logistic regression.A total of 23,101 participants completed the survey. Among the participants, 79.89% (n = 18,457) completed the prescribed three-dose regimen, demonstrating high adherence. Older adults (≥61 years) exhibited the highest adherence (84.63%), whereas younger individuals had lower adherence rates. Employment status, gender and socio-economic class were significant predictors of adherence. Participants with a lower perceived risk of COVID-19 showed higher adherence (adjusted odds ratio = 1.86; 95% confidence interval, 1.73 to 1.99; p < 0.0001). Adverse events were reported by 0.1% (n = 22) of participants, with no serious effects observed.The high adherence to Arsenicum album 30C highlights the effectiveness of a structured government distribution program and the potential of homeopathy as a welcomed medication in aiming to enhance public health.

  • Open Access

    Anti-Neuropathic Efficacy of Homoeopathic Dilutions of Toxicodendron pubescens: A Preclinical Study

    by Nikhila Shekhar, Anil Khurana, Debadatta Nayak, Ajit Kumar Thakur

    Background: Toxicodendron pubescens Mill., the botanical name of Rhus toxicodendron (Rhus tox), also known as ‘poison ivy’, belongs to the family of Anacardiaceae and is widely used in the traditional system of Homoeopathy medicine. Its crude form and various dilutions are most commonly used to relieve arthritis symptoms, are beneficial as an anti-inflammatory and are also used for edema-related conditions. Aim: The study aims to evaluate the anti-neuropathic efficacy of the crude and diluted forms of Rhus tox, a homoeopathic preparation, using the chronic constriction injury (CCI) rat model. Methods: In the current study, before conducting the in vivo study, the cell viability study on Rhus tox dilutions was determined using the MTT assay with Lipopolysaccharide-treated U-87 glioblastoma cells. Consequently, the effect of the drug on mechanical, cold, and hot allodynia and motor nerve conduction velocity was determined. The levels of antioxidants, proinflammatory markers, and histopathological changes were also evaluated. Results: The 14-day treatment regimen with Rhus tox in the chronic constriction model mitigated behavioural alterations such as mechanical and thermal allodynia with an improvement in the conduction velocity in the sciatic nerve as compared to the corresponding groups. The dilutions were also capable of normalising the altered oxidative and inflammatory markers. The anti-neuropathic efficacy was further confirmed by the improved nerve architecture and reduced infiltration of inflammatory cells in histopathological examination. Conclusion: The present observations support the efficacy of ultra-dilutions of Rhus tox in the rodent CCI model of neuropathic pain through its antioxidant, anti-inflammatory, and modulatory effects on neuropathic pain. Major Findings: Rhus tox showed a cytoprotective effect on LPS-induced U-87 glioblastoma cells. Treatment with Rhus tox in CCI rats attenuated thermal and mechanical allodynia and normalised the nerve conduction. Rhus tox normalised oxidative stress and inflammatory levels, improved nerve architecture, and reduced inflammatory cell infiltration.

  • Impact of Homeoprophylactic Arsenicum album 30c on COVID-19 Vaccine-related Adverse Events: A Combined Retrospective–Prospective Cohort Study

    by Debadatta Nayak, Ruchika Bhalla, Lovepreet Kaur, Divya Bansal, Smita Singh, Navita Bagdi, James Michael, Abhishek Chaudhuri, Lalit Tyagi, Bhavna Makhija, et al.

    Arsenicum album 30C (AA30) was recommended by the Government of India for the prevention of coronavirus infection. In the wake of the reporting of COVID-19 vaccine-related adverse events (AEs) and consequent vaccine hesitancy, this study was undertaken to assess the impact of homeo-prophylactic AA30 on COVID-19 vaccine-related AEs. This was a combined retrospective–prospective cohort study that included participants who had been enrolled in an ongoing prospective, parallel cohort study being conducted in urban slums of New Delhi and who had received either or both doses of the COVID-19 vaccine. The reporting of COVID-19 vaccine-related AEs was compared between a cohort that had been receiving homeopathic AA30 as a prophylactic for influenza-like/COVID-like illness with one in which no homeopathic intervention was provided. A total of 1,737 participants who received either or both doses of vaccination for COVID-19 were included in the study, out of whom 436 participants were from the medicine cohort (MC) and 1,301 were from the control cohort (CC). Overall odds of developing AEs after either dose of COVID-19 vaccine in MC as compared with CC was found to be statistically significantly lower (overall crude OR = 0.29, 95% confidence interval [CI] = 0.23 to 0.37; p = 0.0001). The adjusted OR after accounting for age, sex, co-morbidities and vaccine type was 0.30 (95% CI = 0.24 to 0.39; p = 0.0001). The protective effect of the medicine against post-vaccination AEs was evident after the first dose as well as after the second dose, with overall crude OR being 0.37 (95% CI = 0.29 to 0.48; p = 0.0001) and 0.28 (95% CI = 0.19 to 0.41; p = 0.0001) respectively. Prior use of the homeopathic medicine AA30 was able to significantly reduce COVID-19 vaccine-related AEs.


  • Open Access

    Attenuation of hTERT-dependent pathways by Hydrastis canadensis as a novel mechanism for inhibiting breast cancer cell proliferation

    by Sabiha Khan, Saurabh Sharma, Chanderdeep Tandon, Debadatta Nayak, Raj Manchanda, Kshama Kumari, Ibha Singh, Prakash Baligar, Simran Tandon

    Breast cancer (BCa) is marked by uncontrolled cell division, causing the reactivation of the multi-unit ribonucleoprotein telomerase enzyme by expression of the catalytic telomerase reverse transcriptase (hTERT) subunit. Targeting hTERT can therefore offer an advantage in BCa management. Medicinal plants such as Hydrastis canadensis, used in homeopathy has therefore been explored for BCa treatment. Hydrastis canadensis mother tincture (MT) showed the presence of phytoactive components exhibiting anti-cancerous potential. The components were identified by GC-MS analysis and 45 phytochemicals were then screened using in-silico tools. The protein targets of the active components were predicted by submitting the Simplified Molecular Input Line Entry System (SMILES) of the compounds to SwissTargetPrediction, giving active components targeting the hTERT protein. Molecular docking studies were performed on AutoDock 4.2 and Molecular Dynamics (MD) simulation studies on GROningen MAchine for Chemical Simulations (GROMACS) 2023.2. The MM/PBSA calculations were performed with the gmxMMPBSA package. The data was then validated through wet lab experiments, Linoleic acid and Gadoleic acid, as modulators of human telomerase reverse transcriptase (hTERT) were identified, influencing cancer cell survival. The results highlighted the mechanistic role of Hydrastis candensis to target the key oncogenic protein hTERT operative in breast cancer with potential therapeutic applications in cancer treatment.